Literature DB >> 24254916

P2X4 receptors control the fate and survival of activated microglia.

Nuria Vázquez-Villoldo1, María Domercq, Abraham Martín, Jordi Llop, Vanessa Gómez-Vallejo, Carlos Matute.   

Abstract

Microglia, the resident immune cells of the central nervous system, responds to brain disarrangements by becoming activated to contend with brain damage. Here we show that the expression of P2X4 receptors is upregulated in inflammatory foci and in activated microglia in the spinal cord of rats with experimental autoimmune encephalomyelitis (EAE) as well as in the optic nerve of multiple sclerosis patients. To study the role of P2X4 receptors in microgliosis, we activated microglia with LPS in vitro and in vivo. We observed that P2X4 receptor activity in vitro was increased in LPS-activated microglia as assessed by patch-clamp recordings. In addition, P2X4 receptor blockade significantly reduced microglial membrane ruffling, TNFα secretion and morphological changes, as well as LPS-induced microglial cell death. Accordingly, neuroinflammation provoked by LPS injection in vivo induced a rapid microglial loss in the spinal cord that was totally prevented or potentiated by P2X4 receptor blockade or facilitation, respectively. Within the brain, microglia in the hippocampal dentate gyrus showed particular vulnerability to LPS-induced neuroinflammation. Thus, microglia processes in this region retracted as early as 2 h after injection of LPS and died around 24 h later, two features which were prevented by blocking P2X4 receptors. Together, these data suggest that P2X4 receptors contribute to controlling the fate of activated microglia and its survival.
Copyright © 2013 Wiley Periodicals, Inc.

Entities:  

Keywords:  EAE and multiple sclerosis; P2X4 purinergic receptor; cell death; microglia

Mesh:

Substances:

Year:  2013        PMID: 24254916     DOI: 10.1002/glia.22596

Source DB:  PubMed          Journal:  Glia        ISSN: 0894-1491            Impact factor:   7.452


  30 in total

Review 1.  The Purinergic System as a Pharmacological Target for the Treatment of Immune-Mediated Inflammatory Diseases.

Authors:  Luca Antonioli; Corrado Blandizzi; Pál Pacher; György Haskó
Journal:  Pharmacol Rev       Date:  2019-07       Impact factor: 25.468

Review 2.  Implication of Neuronal Versus Microglial P2X4 Receptors in Central Nervous System Disorders.

Authors:  Alexia Duveau; Eléonore Bertin; Eric Boué-Grabot
Journal:  Neurosci Bull       Date:  2020-09-05       Impact factor: 5.203

3.  A Kv1.3 channel-specific blocker alleviates neurological impairment through inhibiting T-cell activation in experimental autoimmune encephalomyelitis.

Authors:  Xiao-Lu Yuan; Yi-Peng Zhao; Jie Huang; Jun-Chen Liu; Wen-Qian Mao; Jun Yin; Bi-Wen Peng; Wan-Hong Liu; Song Han; Xiao-Hua He
Journal:  CNS Neurosci Ther       Date:  2018-03-25       Impact factor: 5.243

4.  Evans Blue Might Produce Pathologically Activated Neuroprotective Effects via the Inhibition of the P2X4R/p38 Signaling Pathway.

Authors:  Mengxiang Yang; Yi Feng; Sicheng Yan; Zhuoying Wu; Xiao Xiao; Jingcheng Sang; Shazhou Ye; Fufeng Liu; Wei Cui
Journal:  Cell Mol Neurobiol       Date:  2020-05-07       Impact factor: 5.046

5.  Role of purinergic receptors in hepatobiliary carcinoma in Pakistani population: an approach towards proinflammatory role of P2X4 and P2X7 receptors.

Authors:  Arun Asif; Madiha Khalid; Sobia Manzoor; Hassam Ahmad; Aman Ur Rehman
Journal:  Purinergic Signal       Date:  2019-08-10       Impact factor: 3.765

6.  P2X4 receptor regulates alcohol-induced responses in microglia.

Authors:  Larisa Gofman; Jonathan M Cenna; Raghava Potula
Journal:  J Neuroimmune Pharmacol       Date:  2014-08-20       Impact factor: 4.147

7.  Neurons and Glial Cells Are Added to the Female Rat Anteroventral Periventricular Nucleus During Puberty.

Authors:  Margaret A Mohr; Francisca L Garcia; Lydia L DonCarlos; Cheryl L Sisk
Journal:  Endocrinology       Date:  2016-05-04       Impact factor: 4.736

8.  Deletion of the P2X4 receptor is neuroprotective acutely, but induces a depressive phenotype during recovery from ischemic stroke.

Authors:  Rajkumar Verma; Chunxia G Cronin; Jacob Hudobenko; Venugopal R Venna; Louise D McCullough; Bruce T Liang
Journal:  Brain Behav Immun       Date:  2017-07-24       Impact factor: 7.217

Review 9.  MicroRNA: Crucial modulator in purinergic signalling involved diseases.

Authors:  Jing Guo; Peng Yang; Yi-Fan Li; Jin-Fan Tang; Zhao-Xuan He; Shu-Guang Yu; Hai-Yan Yin
Journal:  Purinergic Signal       Date:  2022-02-02       Impact factor: 3.765

Review 10.  Targeting Neuroinflammation via Purinergic P2 Receptors for Disease Modification in Drug-Refractory Epilepsy.

Authors:  Tobias Engel; Jonathon Smith; Mariana Alves
Journal:  J Inflamm Res       Date:  2021-07-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.